Clinical Trial Update: Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery [Phase 2]

View source ↗

Summary

This update reports Phase 2 pharmacokinetic data for BIBR 1048 in patients after primary elective total hip replacement, in a trial addressing venous thromboemb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• BIBR 1048

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED